The Patent Finder

Shanghai Allist Pharmaceuticals Co., Ltd.

13 patents currently held · Updated Nov 21, 2026
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

6
Ending by 2030
Feb 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Feb 11, 2027
    The maintenance fee for Polymorphic forms of 4-phenylamine quinazoline derivative, the preparation method and uses thereof (US 9,102,629) comes due Feb 11, 2027. Unpaid by Aug 11, 2027, it lapses early.
  • 1 fee due May 12, 2027
    The maintenance fee for Salt of pyridinyl amino pyrimidine derivative, preparation method therefor, and application thereof (US 10,472,349) comes due May 12, 2027. Unpaid by Nov 12, 2027, it lapses early.
  • 1 fee due Jul 28, 2027
    The maintenance fee for Fused pyrimidine piperidine cyclic derivative, preparation process and use thereof (US 10,544,144) comes due Jul 28, 2027. Unpaid by Jan 28, 2028, it lapses early.
  • 1 fee due Aug 4, 2027
    The maintenance fee for Crystalline forms of mesylate salt of pyridinyl amino pyrimidine derivative, preparation methods therefor, and applications thereof (US 10,550,101) comes due Aug 4, 2027. Unpaid by Feb 4, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 term has ended since Aug 23, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,044,063Quinazoline derivatives useful as anti-tumor medicament
In force
 · USPTO record
In forceUSPTO record
US 8,349,854Salts of 4-aniline quinazoline derivative
In force
 · USPTO record
In forceUSPTO record
US 8,338,438Polymorph forms of 4-anilinoquinazoline derivatives, the preparation methods and uses thereof
In force
 · USPTO record
In forceUSPTO record
US 8,937,079Polymorph forms of 4-anilinoquinazoline derivatives, the preparation methods and uses thereof
In force
 · USPTO record
In forceUSPTO record
US 9,102,629Polymorphic forms of 4-phenylamine quinazoline derivative, the preparation method and uses thereof
In force
 · USPTO record
In forceUSPTO record
US 8,507,010Compositions comprising quinazoline derivatives
In force
 · USPTO record
In forceUSPTO record
US 8,871,726C-aryl glucoside derivative, preparation method therefor, and use thereof
In force
 · USPTO record
In forceUSPTO record
US 8,952,002Aminoheteroaryl compounds and preparation method and use thereof
In force
 · USPTO record
In forceUSPTO record
US RE48,687Pyridinylaminopyrimidine Derivatives, Preparation Process and Use Thereof
In force
 · Low confidence
In forceLow confidence
US RE49,851Pyridinylaminopyrimidine Derivatives, Preparation Process and Use Thereof
In force
 · Low confidence
In forceLow confidence
10 of 13 patents shown.
Pro members see all 13.
Pro members: see all 13 patents
Also on record, not counted in the 13: 1 patent in force now held by others · 3 lapsed for an unpaid fee · 1 ended at full term · 2 surrendered on reissue. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

3 pending · 1 abandoned

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited